X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3146) 3146
Newsletter (1416) 1416
Publication (385) 385
Book Review (22) 22
Book Chapter (21) 21
Newspaper Article (14) 14
Book / eBook (7) 7
Journal / eJournal (5) 5
Web Resource (5) 5
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Data Set (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
kala-azar (4201) 4201
parasitic diseases (1841) 1841
humans (1740) 1740
visceral leishmaniasis (1561) 1561
animals (1346) 1346
index medicus (1317) 1317
research (1186) 1186
male (1036) 1036
female (1029) 1029
leishmaniasis (874) 874
tropical medicine (797) 797
parasitology (785) 785
diagnosis (716) 716
infectious diseases (698) 698
medical research (676) 676
adult (675) 675
medicine, experimental (628) 628
immunology (618) 618
leishmaniasis, visceral - epidemiology (562) 562
leishmaniasis, visceral - drug therapy (531) 531
health aspects (525) 525
leishmaniasis, visceral - diagnosis (524) 524
child (477) 477
adolescent (467) 467
analysis (462) 462
leishmaniasis, visceral - immunology (454) 454
leishmaniasis, visceral - parasitology (446) 446
dogs (445) 445
infection (432) 432
epidemiology (418) 418
cutaneous leishmaniasis (412) 412
middle aged (405) 405
public, environmental & occupational health (405) 405
microbiology (394) 394
care and treatment (390) 390
antiprotozoal agents - therapeutic use (364) 364
parasites (360) 360
child, preschool (359) 359
india (340) 340
research article (328) 328
risk factors (325) 325
infections (292) 292
tropical diseases (290) 290
mice (285) 285
vaccines (284) 284
leishmania donovani (281) 281
medicine (274) 274
leishmania (267) 267
donovani (266) 266
arctic medicine. tropical medicine (256) 256
antigens (249) 249
young adult (244) 244
leishmania donovani - immunology (238) 238
leishmaniasis, visceral - veterinary (235) 235
leishmaniasis, visceral - prevention & control (233) 233
infant (231) 231
public health (224) 224
antibodies, protozoan - blood (222) 222
vector-borne diseases (221) 221
leishmaniasis, visceral - complications (220) 220
disease transmission (215) 215
sensitivity and specificity (215) 215
brazil (214) 214
enzyme-linked immunosorbent assay (212) 212
public aspects of medicine (211) 211
zoonoses (210) 210
leishmania infantum (205) 205
amphotericin b (195) 195
drug therapy (194) 194
sudan (194) 194
leishmaniasis, visceral - transmission (188) 188
sodium stibogluconate (185) 185
amphotericin b - therapeutic use (181) 181
infantum (180) 180
usage (177) 177
direct agglutination-test (176) 176
polymerase chain reaction (176) 176
mice, inbred balb c (173) 173
antigens, protozoan - immunology (172) 172
interferon-gamma (172) 172
aged (171) 171
leishmaniasis, visceral - pathology (171) 171
veterinary sciences (171) 171
drug resistance (167) 167
azar dermal leishmaniasis (165) 165
leishmania donovani - isolation & purification (164) 164
neglected tropical diseases (163) 163
treatment outcome (163) 163
medicine and health sciences (160) 160
t cells (160) 160
cytokines (159) 159
liposomal amphotericin-b (157) 157
india - epidemiology (155) 155
dna (152) 152
hiv (151) 151
biology and life sciences (150) 150
indian kala-azar (149) 149
medicine, general & internal (146) 146
dog diseases - parasitology (145) 145
miltefosine (145) 145
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4488) 4488
French (35) 35
Spanish (32) 32
Portuguese (30) 30
German (11) 11
Persian (7) 7
Turkish (4) 4
Italian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Web Resource
2011
Papers presented at a workshop on Policy issues in Kala azar in South East Asia, held at New Delhi on 27th November 2009. 
Prevention | Kala-azar
Conference Proceeding
Post-kala-azar dermal leishmaniasis: a histopathological study, 12/2005
BACKGROUND : Post-kala-azar dermal leishmaniasis follows an attack of visceral leishmaniasis and is caused by the same organism, i.e. Leishmania donovani .... 
Post kala-azar dermal leishmaniasis, Hypopigmented macules, Nodules, Plaques, Histopathology
Journal
Management of visceral leishmaniasis: Indian perspective, 12/2005
Diagnosis and treatment of Indian visceral leishmaniasis (VL) is extremely unsatisfactory. For diagnosis, demonstration of parasites in splenic/marrow smears... 
Amphotericin B, kala-azar, miltefosine, paromomycin, pentavalent antimony, visceral leishmaniasis
Journal
Human Immunology, ISSN 0198-8859, 08/2018, Volume 79, Issue 8, p. 616
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.humimm.2018.05.004 This... 
Kala-azar | Microbiology | Analysis
Journal Article
07/2013
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatologic manifestation that usually occurs after visceral leishmaniasis (VL) caused by Leishmania donovani... 
treatment | Miltefosine | Bangladesh | Mucosal involvement | Post-kala-azar dermal leishmaniasis
Web Resource
Mucosal and peri-orificial involvement in post-kala-azar dermal leishmaniasis, 09/2004
BACKGROUND AND AIMS: Lesions of post-kala-azar dermal leishmaniasis (PKDL) usually affect the skin. Uncommonly, the involvement of oral and genital mucosae has... 
Dermatology | Post-kala-azar dermal leishmaniasis, oral mucosa, genital lesions, peri-orificial lesions dv04096
Journal
Evaluation of cholinesterase level in an endemic population exposed to malathion suspension formulation as a vector control measure, 03/2004
The manuscript describes a study on the blood cholinesterase (ChE) level in an exposed population at different interval of time after spraying with malathion... 
Tropical Diseases | Microbiology | SRES-slow release emulsified suspension - ChE-cholinesterase - kala-azar - Phlebotomus argentipes. oc04039
Journal
Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis (PKDL), 11/2003
Drugs used in PKDL include parenteral sodium antimony gluconate (SAG), amphotericin-B, pentamidine, and ketoconazole (KTZ). SAG is the most effective one.... 
Dermatology | Post-kala-azar dermal leishmaniasis, Sodium antimony gluconate, Ketoconazole dv03073
Journal
Chinese Journal of Schistosomiasis Control, ISSN 1005-6661, 10/2017, Volume 29, Issue 5, pp. 541 - 543
Journal Article
Bulletin de la Societe de pathologie exotique, ISSN 0037-9085, 10/2015, Volume 108, Issue 4, p. 265
La leishmaniose viscerale (LV) constitue un probleme de sante publique en Tunisie. L'objectif de ce travail est d'actualiser les aspects epidemiologiques,... 
Kala-azar | Epidemiology
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 05/2018, Volume 37, Issue 5, pp. 419 - 423
BACKGROUND:Visceral leishmaniasis (VL) remains a public health issue in Greece. The aim of this study was to describe the clinical and epidemiologic... 
Kala-azar | Care and treatment | Diagnosis | Children | Diseases
Journal Article
1996, Cuaderno técnico / Organización Panamericana de la Salud, ISBN 9275330441, Volume no. 44, ix, 51
Book
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 10/2019, Volume 69, Issue 7, pp. 1130 - 1135
Background. Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a fatal, neglected tropical disease that is targeted for elimination in... 
INFECTIOUS DISEASES | relapse | MICROBIOLOGY | IgG1 | rapid diagnostic test | KALA-AZAR | cure | IMMUNOLOGY | visceral leishmaniasis
Journal Article
Parasite Immunology, ISSN 0141-9838, 11/2016, Volume 38, Issue 11, p. 698
Canine visceral leishmaniasis (CVL) is caused by the intracellular parasite Leishmania infantum. Increased levels of arginase, nitric oxide (NO.sub.2) and... 
Kala-azar | Tumor necrosis factor | Prostaglandins E
Journal Article
10/2011
In visceral leishmaniasis, phlebotomine vectors are targets for control measures. Understanding the ecosystem of the vectors is a prerequisite for creating... 
Phlebotomus argentipes - Kala-azar - CDC light trap - RS image - NDVI - landscape
Web Resource
Trends in Parasitology, ISSN 1471-4922, 02/2019, Volume 35, Issue 2, pp. 97 - 101
Visceral leishmaniasis, caused by , is a zoonosis, and culling seropositive dogs has been recommended to control the disease in some endemic countries.... 
pyrethroids | Leishmania infantum | culling | dogs | canine leishmaniosis | control | zoonosis | PARASITOLOGY | Kala-azar | Zoonoses
Journal Article
Journal of immunological methods, ISSN 0022-1759, 06/2019, Volume 469, pp. 18 - 25
Visceral Leishmaniasis (VL) is a severe disease, caused by the protozoans Leishmania infantum and L. donovani that is widely diagnosed using serological tools.... 
Kala-azar | Immunoglobulin G | Fluorescein
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.